Chinese online pharmacy and healthcare service platform Jianke on Tuesday announced that it has raised US$130 million in series B financing led by GTJA Investment Group. European healthcare investment firm HBM Healthcare Investments and Asia-focused private equity firm Crescent Point also participated in this round, the company said in a statement. The latest round values the company between US$500 million and US$600 million. The company is also planning to complete one more private fundraising round before going public in the United States …

GTJA Investment Group Leads $130M Series B Round In Chinese Online B2C Pharmacy Jianke appeared first on China Money Network.